Prt1

PF3D7_0322100 (Prt1) is an essential Plasmodium falciparum RNA 5'-triphosphatase that catalyzes the first step of nuclear mRNA capping (PMID:11248030, PMID:38810336). It belongs to the fungal/viral family of metal-dependent phosphohydrolases and is structurally and mechanistically distinct from the cysteine-phosphatase-type RNA triphosphatases of metazoans and plants, and it operates as a separate enzyme from the RNA guanylyltransferase Pgt1 within the parasite's capping apparatus (PMID:11248030). Genetic loss-of-function analysis established that Prt1 is required for P. falciparum viability, and the recombinant protein is amenable to purification and enzymatic activity assessment consistent with its assigned triphosphatase role (PMID:38810336). Beyond its enzymatic classification, essentiality, and separation from Pgt1, no structural model or catalytic-residue mutagenesis of Prt1 has been characterized in the available corpus.

1. 2001 Medium

   Establishing how P. falciparum removes the 5'-gamma-phosphate of nascent mRNA answered which enzyme catalyzes the first capping step and revealed a mechanism distinct from the host, defining a candidate drug target class.

   Evidence Biochemical characterization and phylogenetic/sequence analysis of expressed P. falciparum Prt1 protein

   PMID:11248030

   Open questions at the time

   • No structural model or catalytic-residue mutagenesis reported
   • Physical/functional coupling between Prt1 and Pgt1 not resolved
   • Metal-ion requirement not defined at the mechanistic level in the abstract
2. 2024 Medium

   Testing whether Prt1 is dispensable answered its value as a target: genetic loss-of-function showed the enzyme is essential for parasite viability, and recombinant activity assays confirmed its triphosphatase function.

   Evidence Genetic essentiality validation, recombinant protein purification, enzymatic activity assay, and target engagement assessment

   PMID:38810336

   Open questions at the time

   • No structural or mutagenesis data described
   • Target-engagement assay not tied to a validated inhibitor mechanism in the abstract
   • Stage-specificity of essentiality not defined

• The structural basis of Prt1 catalysis, its metal coordination, and how it functionally coordinates with the guanylyltransferase Pgt1 during capping remain unresolved.
• No crystal or cryo-EM structure of Prt1
• Catalytic and metal-binding residues not mapped by mutagenesis
• Mechanism of coordination with Pgt1 in the capping apparatus unknown